EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSCMIG00000013598
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Transthyretin

Ensembl ID : ENSCMIG00000000473
Gene Symbol: TTR
3 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCMIG00000011275
Gene Symbol: TPH1
3 Cross references
258 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSCMIG00000015997
Gene Symbol: LOC103189642
3 Cross references
228 Possible Orthologues:

Tubulin Alpha-1 Chain-Like

Ensembl ID : ENSCMIG00000003435
Gene Symbol: LOC103173988
3 Cross references
267 Possible Orthologues:

Tubulin Alpha-1 Chain-Like

Ensembl ID : ENSCMIG00000003029
Gene Symbol: LOC103172121
3 Cross references
266 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSCMIG00000014949
Gene Symbol: TUBB1
1 Cross references
120 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSCMIG00000015186
Gene Symbol: TUBB3
2 Cross references
171 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCMIG00000000881
Gene Symbol: LOC103174162
3 Cross references
364 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCMIG00000007236
Gene Symbol: LOC103190291
2 Cross references
174 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSCMIG00000014642
Gene Symbol: LOC103191424
2 Cross references
193 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSCMIG00000012677
Gene Symbol: LOC103184559
2 Cross references
226 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).